Financials
Financial year 2025
Apotheek Bontinck from Wichelen, company number BE0426452481, closed financial year 2025 with a result of € 181,096 after tax. For that financial year Apotheek Bontinck recorded a gross margin of € 442,559 and equity of € 943,761. Compared with financial year 2024, the result moved from € 191,599 to € 181,096. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 10, 2026.
€ 943,761
▲ 9% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 181,096
▼ 5% vs 2024
Profit after tax over the fiscal year.
€ 298,507
▼ 35% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 106,209 paid out
59 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
1.6
▲ 0.1 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 114,314
▼ 5% vs 2024
€ 71,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 85,748
▼ 28% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 106,947
▲ 20% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 40,372
▲ 13% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 276,696 | € 291,893 | € 375,062 | € 442,559 | ▲ 18% |
| Profit after taxes | € 77,943 | € 98,276 | € 191,599 | € 181,096 | ▼ 5% |
| Equity | € 804,000 | € 902,276 | € 868,875 | € 943,761 | ▲ 9% |
| Total debts | € 301,306 | € 320,696 | € 475,998 | € 209,037 | ▼ 56% |
| Cash | € 838,935 | € 681,743 | € 460,687 | € 298,507 | ▼ 35% |
| Land & buildings | € 90,508 | € 102,872 | € 109,399 | € 110,048 | ▲ 1% |
| Retained profit | € 451,000 | € 549,276 | € 740,875 | € 815,761 | ▲ 10% |
| Dividend | € 0 | € 0 | € 0 | € 106,209 | |
| Bank debt | € 1,041 | € 1,041 | € 1,041 | € 0 | ▼ 100% |
| Balance sheet total | € 1,105,306 | € 1,222,972 | € 1,344,873 | € 1,152,798 | ▼ 14% |
| Employees (FTE) | 2.1 | 1.6 | 1.5 | 1.6 | ▲ 0.1 |
Key figures of Apotheek Bontinck, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Apotheek Bontinck?
What happened at Apotheek Bontinck in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 181,096 (▼ 5% vs 2024). Source: NBB ↗
- Robbe Detant became a director. NBB
- Nathalie Bontinck became a director. NBB
- New establishment in Wichelen. KBO
- Start of the company according to the CBE. KBO
In short
From € 77,943 profit in 2022 to € 181,096 profit in 2025.
Paid € 237,009 in corporate taxes since 2022.
Best year ever: 2024, with € 191,599 profit.
On average € 276,600 of value added per employee in 2025.
A new publication or filing at Apotheek Bontinck? We notify you, reason included.
Follow Apotheek BontinckDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Apotheek Bontinck are Robbe Detant and Nathalie Bontinck.
Directors
According to the 2025 annual accounts
Robbe Detant
Director
since 2024
Nathalie Bontinck
Director
since 2024
Establishments
Establishment units
Physical locations of this company
Hoogstraat 33
9260 Wichelen
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0426.452.481
- VAT number
- BE 0426.452.481
- Registered office
- Hoogstraat 33, 9260 Wichelen
- Names & denominations
- Apotheek Bontinck
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 28 November 1984
- Peppol
- Active · Active since 20 Jan 2026
- Activities · NACE
Apothekers
Detailhandel in farmaceutische producten